Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Chronic osteomyelitis remains a clinical challenge in orthopedics. Methods: In this study, silk fibroin microspheres (SFMPs) loaded with vancomycin are entrapped in an injectable silk hydrogel to form a vancomycin delivery system for treatment of chronic osteomyelitis. Results and Discussion: Vancomycin showed continuous release from the hydrogel for up to 25 days. The hydrogel shows strong antibacterial activity against both Escherichia coli and Staphylococcus aureus and a long antibacterial duration of 10 days without a decrease in the antibacterial effect. The injection of vancomycin-loaded silk fibroin microspheres entrapped in the hydrogel into the infected site of rat tibia reduced bone infection and improved bone regeneration compared with other treatment groups. Conclusion: Thus, the composite SF hydrogel features a sustained-release profile and good biocompatibility, making it promising for application in osteomyelitis treatment.

Cite

CITATION STYLE

APA

Zhang, P., Sun, Y., Yang, H., Liu, D., Zhang, F., Zhang, Y., … Zhou, Z. (2023). Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1163933

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free